Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Core EBITDA Growth

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Core EBITDA Growth(%) 25.857.7265.570.03-4.21

What is the latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) is 25.85 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202425.85
Mar20237.72
Mar202265.57
Mar20170.03
Mar2016-4.21

How is Core EBITDA Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 25.85
234.84
Mar2023 7.72
-88.23
Mar2022 65.57
218,466.67
Mar2017 0.03
Positive
Mar2016 -4.21 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Core EBITDA Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,545.4 Cr 5.6% 1.9% 13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,588.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹157,711.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,115.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,589.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,746.6 Cr 3.1% 9.8% -7.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.6%

1.9%

13.2%

SENSEX

2%

9.4%

11.6%


You may also like the below Video Courses